Parametric Portfolio Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$8.67M Buy
73,100
+18,226
+33% +$2.16M ﹤0.01% 1465
2021
Q4
$7.56M Sell
54,874
-23,242
-30% -$3.2M ﹤0.01% 1577
2021
Q3
$10.9M Buy
78,116
+31,913
+69% +$4.43M 0.01% 1299
2021
Q2
$4.49M Buy
46,203
+28,171
+156% +$2.73M ﹤0.01% 1916
2021
Q1
$1.23M Sell
18,032
-11,559
-39% -$790K ﹤0.01% 3066
2020
Q4
$2.54M Buy
29,591
+2,948
+11% +$253K ﹤0.01% 2509
2020
Q3
$1.73M Sell
26,643
-2,562
-9% -$167K ﹤0.01% 2595
2020
Q2
$2.14M Buy
29,205
+14,287
+96% +$1.04M ﹤0.01% 2461
2020
Q1
$508K Buy
14,918
+284
+2% +$9.67K ﹤0.01% 3151
2019
Q4
$797K Buy
14,634
+6,657
+83% +$363K ﹤0.01% 3169
2019
Q3
$333K Sell
7,977
-18,402
-70% -$768K ﹤0.01% 3493
2019
Q2
$1.16M Buy
26,379
+3,116
+13% +$136K ﹤0.01% 2980
2019
Q1
$1.2M Buy
+23,263
New +$1.2M ﹤0.01% 2937
2017
Q4
Sell
-17,817
Closed -$666K 4032
2017
Q3
$666K Buy
+17,817
New +$666K ﹤0.01% 3264